Cargando…
I-FABP is decreased in COVID-19 patients, independently of the prognosis
BACKGROUND: Severe acute respiratory syndrome caused by the novel coronavirus (SARS-CoV-2) is frequently associated with gastrointestinal manifestations. Herein we evaluated the interest in measuring the intestinal fatty acid-binding protein (I-FABP), a biomarker of intestinal injury, in COVID-19 pa...
Autores principales: | Guedj, Kevin, Uzzan, Mathieu, Soudan, Damien, Trichet, Catherine, Nicoletti, Antonino, Weiss, Emmanuel, Manceau, Hana, Nuzzo, Alexandre, Corcos, Olivier, Treton, Xavier, Peoc’h, Katell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8049236/ https://www.ncbi.nlm.nih.gov/pubmed/33857216 http://dx.doi.org/10.1371/journal.pone.0249799 |
Ejemplares similares
-
Patients with COVID-19 present with low plasma citrulline concentrations that associate with systemic inflammation and gastrointestinal symptoms
por: Uzzan, Mathieu, et al.
Publicado: (2020) -
Accuracy of citrulline, I-FABP and d-lactate in the diagnosis of acute mesenteric ischemia
por: Nuzzo, Alexandre, et al.
Publicado: (2021) -
Ferroptosis in Liver Diseases: An Overview
por: Capelletti, Martina Maria, et al.
Publicado: (2020) -
Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics – Lung axis hypothesis
por: Uzzan, Mathieu, et al.
Publicado: (2020) -
Reversible atransferrinemia in a patient with chronic enteropathy: is transferrin mandatory for iron transport?
por: Raynor, Alexandre, et al.
Publicado: (2022)